跳至主要内容
临床试验/NCT04538781
NCT04538781已完成不适用

AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry

Cardiva Medical, Inc.4 个研究点 分布在 1 个国家目标入组 497 人开始时间: 2020年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
497
试验地点
4
主要终点
Freedom from next day access site closure-related complications requiring hospital intervention

研究概览

简要总结

A multi-center, retrospective, single arm post market registry to evaluate procedural outcomes data using the Cardiva VASCADE MVP Venous Vascular Closure System (VVCS) for the management of the femoral venotomy after catheter-based atrial fibrillation interventions with or without another arrythmia performed via 6-12F procedural sheaths with single or multiple access sites per limb for patients who are discharged the same day.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age;
  • Underwent catheter-based ablation for atrial fibrillation with or without another arrythmia.
  • VASCADE MVP was the only closure device utilized.
  • Were discharged the same calendar day as the index procedure.
  • Completed a SOC follow-up > 7 days post-procedure.

排除标准

  • Any additional procedure(s) involving femoral arterial or venous access in either limb within the SOC follow up period as defined by each site (minimum 7 days post-procedure)

结局指标

主要结局

Freedom from next day access site closure-related complications requiring hospital intervention

时间窗: 1 day

Primary Performance Outcome

rate of major venous access site closure-related complications

时间窗: ≥7 days

Major Complication rate

次要结局

  • Freedom from access site closure-related complications requiring hospital intervention through standard of care follow up contact(≥7 days)
  • minor venous access site closure-related complications(≥7 days)
  • Freedom from next day procedure-related complications requiring hospital intervention(1 day)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验